FoxP3+ TI Tregs from gastric cancer patients were shown to exert suppressive activity via production of cyclooxygenase-2 (COX-2) and prostaglandin E-2 (PGE-2) [48]. This evidence concerns the gene PTGS2 and gastric cancer.